AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 98 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $15,760,000 | -26.1% | 25,243,865 | 0.0% | 0.74% | -57.8% |
Q3 2019 | $21,318,000 | +26.0% | 25,243,865 | 0.0% | 1.76% | +48.9% |
Q2 2019 | $16,913,000 | -1.3% | 25,243,865 | +20.8% | 1.18% | +33.1% |
Q1 2019 | $17,135,000 | -48.7% | 20,896,038 | 0.0% | 0.89% | -32.9% |
Q4 2018 | $33,434,000 | -46.0% | 20,896,038 | +11.8% | 1.33% | -50.4% |
Q3 2018 | $61,891,000 | +54.4% | 18,698,038 | +5.1% | 2.67% | +42.2% |
Q2 2018 | $40,091,000 | -15.5% | 17,783,722 | +8.7% | 1.88% | -11.0% |
Q1 2018 | $47,452,000 | +3.9% | 16,362,694 | 0.0% | 2.11% | +11.6% |
Q4 2017 | $45,652,000 | -23.6% | 16,362,694 | 0.0% | 1.89% | -9.6% |
Q3 2017 | $59,724,000 | +64.4% | 16,362,694 | 0.0% | 2.09% | +58.2% |
Q2 2017 | $36,325,000 | +276.3% | 16,362,694 | 0.0% | 1.32% | +293.5% |
Q1 2017 | $9,654,000 | +72.5% | 16,362,694 | +57.9% | 0.34% | +50.7% |
Q4 2016 | $5,596,000 | -39.3% | 10,362,694 | 0.0% | 0.22% | -46.1% |
Q3 2016 | $9,223,000 | -7.3% | 10,362,694 | 0.0% | 0.41% | -19.8% |
Q2 2016 | $9,948,000 | – | 10,362,694 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |